The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling - Nicolas-Morala, Jimena; Mascaraque-Checa, Marta; Gallego-Rentero, Maria; Barahona, Andrea; Abarca-Lachen, Edgar; Carrasco, Elisa; Gilaberte, Yolanda; Gonzalez, Salvador; Juarranz, Angeles (International Journal of Biological Sciences, 2024)